目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T2771 | Antioxidant | ||
Orcinol glucoside (Sakakin) 是一种提取自莪术中的活性成分,具有抗抑郁活性。它能诱导 MSC 转化为成骨细胞,并通过 Wnt/β-catenin 信号通路阻断脂肪形成。 | |||
T2423 | Others | ||
P7C3-A20 是促神经原性和神经保护活性的 P7C3 衍生物。它具有抗抑郁活性,能够透过血脑屏障,并可用于研究脑损伤。 | |||
T22052 | Imidazoline Receptor | ||
BU 226 hydrochloride 对咪唑啉受体具有亲和力,尤其是对 I2 结合位点,Ki 为 1.4 nM。 BU 226 hydrochloride 对 alpha 2-adrenoceptors 显示出低 (microM) 亲和力。 | |||
T22605 | MAO Monoamine Oxidase | ||
Bifemelane hydrochloride 是一种选择性的,有效的,和竞争性的单胺氧化酶A (MAO-A)抑制剂,Ki=4.20 μM,它也非竞争性地抑制MAO-B,Ki=46.0 μM。它具有显著的抗抑郁作用,可用于研究与脑血管疾病有关的认知和情绪障碍。 | |||
T18918 | MAO Monoamine Oxidase | ||
Azure B (Azure B chloride) 是一种 Methylene blue 的主要代谢物,是一种阳离子染料,用于 Azure 曙红染色剂以进行血液涂片染色。它是高选择性和可逆的抑制单胺氧化酶(MAO)-A 的抑制剂,对重组人的 MAO-A 和 MAO-B 的IC50分别为 11 和 968 nM。它具有显著的抗抑郁作用。 | |||
T4912 | Others 5-HT Receptor OCT Antibacterial AChE | ||
Jatrorrhizine chloride (Neprotine chloride) 是从黄连中分离得到的生物碱,具有神经保护、抗菌、抗氧化和抗疟原虫活性。它通过抑制摄取2转运蛋白的活性减少血清素和去甲肾上腺素的摄取。它是具有口服活性的乙酰胆碱酯酶抑制剂。 | |||
T13318 | GluR | ||
VU0650786 是能透过中枢神经系统的,选择性谷氨酸受体亚型 3 的一种负变构调节剂,IC50值为 392 nM,有抗抑郁和抗焦虑活性。 | |||
T22453 | Serotonin Transporter | ||
Venlafaxine (Wy 45030) 是一种口服有效的 5-羟色胺 (5-HT)/去甲肾上腺素 (NE) 重摄取的双重抑制剂,具有抗抑郁活性。 | |||
T15090 | GluR | ||
Decoglurant (RO4995819) 是 mGluR2和 mGluR3的负变构调制器,有抗抑郁作用。 | |||
T23070 | Sodium Channel Monoamine Transporter Norepinephrine | ||
Nisoxetine hydrochloride 是一种去甲肾上腺素转运蛋白 (NET) 抑制剂,Kd 值为 0.76 nM。它是抗抑郁药和局部麻药,可以阻断电压门控性钠通道。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPH-00859 | HTR1B Protein, Human, Recombinant (His) | Human | in vitro E. coli expression system | ||
G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for ergot alkaloid derivatives, various anxiolytic and antidepressant drugs and other psychoactive substances, such as lysergic acid diethylamide (LSD). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity. Arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. Regulates the release of 5-hydroxytryptamine, dopamine and acetylcholine in the brain, and thereby affects neural activity, nociceptive processing, pain perception, mood and behavior. Besides, plays a role in vasoconstriction of cerebral arteries.
|
|||||
TMPH-00861 | HTR1D Protein, Human, Recombinant (His & KSI) | Human | E. coli | ||
G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for ergot alkaloid derivatives, various anxiolytic and antidepressant drugs and other psychoactive substances. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity. Regulates the release of 5-hydroxytryptamine in the brain, and thereby affects neural activity. May also play a role in regulating the release of other neurotransmitters. May play a role in vasoconstriction.
|
|||||
TMPH-00860 | HTR1D Protein, Human, Recombinant (hFc) | Human | HEK293 | ||
G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for ergot alkaloid derivatives, various anxiolytic and antidepressant drugs and other psychoactive substances. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity. Regulates the release of 5-hydroxytryptamine in the brain, and thereby affects neural activity. May also play a role in regulating the release of other neurotransmitters. May play a role in vasoconstriction.
|